Navigation Links
Aspire IRB Announces the Launch of an Automated Web Portal System
Date:7/14/2008

2008 Brings New technology for On-line tracking and Document Access

SAN DIEGO, July 14 /PRNewswire/ -- Aspire Independent Review Board, LLC announces the launch of an automated web based system for multi-center trials. A.S.A.P., Aspire's Simple Automated Portal, allows clients to securely log onto a website 24 hours a day, 7 days a week to view up-to-date information regarding their study. The system also allows clients to access approval documents that can be downloaded at their convenience.

Aspire IRB protects the rights of human research participants and reviews the research to make sure that it is well-designed and the risks are as minimal as possible. The FDA and HHS regulations have empowered IRBs to approve, require modifications, or disapprove research. Aspire IRB's reputation and dedication to building relationships in the research industry has been instrumental to its success.

Aspire's continued success is attributed to their ability to adapt to a growing and changing field. "The standards and systems we put in place throughout the stages of the studies we oversee allow us the much needed flexibility to provide immediate responses to the research industry. We are unveiling our new automated on-line system to take us to the next level," states Cathryn Taub, CEO.

To submit a study and gain secure access to the web based system, please contact Michele Baptista, CIP, V.P. of Central IRB Operations at 619-469-0108.

Aspire IRB was created in 2004 by four dynamic women with CIP (Certified IRB Professional) certification and over thirty years experience in the growing field of Independent Review Boards (IRBs). Cathryn Taub, CEO, Alycia Huston, COO, Charlotte Stewart, VP and Michele Baptista, VP worked together and after a meeting of the minds decided their unique blend of expertise was perfect for starting their own IRB organization. They wanted to create a company that was dedicated to setting new standards, daring to be innovative and more responsive in an industry where time is crucial. In addition, they wanted to create a culture that embraced and motivated their employees in a team oriented environment.

About ASPIRE IRB, LLC http://www.aspire-irb.com Aspire IRB is a privately owned and certified Women's Business Enterprise headquartered in San Diego, CA. Aspire IRB is responsible for overseeing clinical research studies. Aspire reviews, approves and monitors any research involving human participants with the aim to protect their rights and welfare. An IRB reviews research to make sure that it is well-designed and the risks are as minimal as possible. The board is made up of physicians, scientists, non scientists, community members and members affiliated with Aspire IRB.

For More Information and to Schedule Interviews: Alycia Huston, COO, 619-469-0108


'/>"/>
SOURCE Aspire Independent Review Board, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
2. VNUS Medical Technologies, Inc. Announces Board of Director Resignation
3. Chindex International, Inc. Announces CDC Contract Signing
4. Perrigo Company Announces Appointment of New Board Member
5. Lutronic Announces FDA Clearance and Immediate Availability of Its eCO2, the First Multi-Functional Fractional CO2 Laser System
6. Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executive Officer
7. Life Record Inc. Announces EmergenKey, My Life Record Family and Personal Edition for the iPhone on the Apple App Store
8. LCA-Vision Announces Upcoming Investment Community Events
9. Merit Medical Pre-Announces Record Sales and Earnings for the Second Quarter Ended June 30, 2008
10. SpectraGenics Announces $30M in New Funding, Changes Company Name to TRIA Beauty
11. Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... May 28, 2016 , ... May 26, 2016- In ... Arts Fighting Challenge with theme event of “K Warriors” on June 4, 2016 at ... , The event is sponsored and hosted by Shaolin Institute and sanctioned by ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Two director-level employees ... YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen ... For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... ... casual readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven ... tech within the industry, from leading advocates, associations and industry leaders such as ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... students studying complementary medicine. Allison Outerbridge is this year’s Life University ... May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, ... respirators, according to court documents and SEC filings. A jury has returned ... v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
Breaking Medicine Technology: